NCT05826821View on ClinicalTrials.gov

Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

November 29, 2019

Study Completion Date

April 29, 2020

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
DRUG

Pirfenidone

Intervention drug

Trial Locations (1)

Unknown

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT05826821 - Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease | Biotech Hunter | Biotech Hunter